http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer
-
Blackstone Energy Transition Partners Announces Acquisition of Alliance Technical Group
-
Surge Announces Increased Investment from The Quaternary Group
-
North Coast Credit Union Launches Mahalo’s Digital Banking Platform to Elevate Member Experience
-
Totus Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Mineralys Therapeutics Provides Corporate Update and Announces Participation in Upcoming LifeSci Partners Corporate Access Event in January 2026
-
Imagine Pediatrics Accelerates Growth into New States and Commercial Health Plan Market to Expand Access and Improve Outcomes for Children with Special Health Care Needs
-
Arrowhead Pharmaceuticals reports interim obesity drug trial results
-
China approves Zai Lab's AUGTYRO for NTRK-positive solid tumors
-
Anavex receives FDA feedback on Alzheimer's disease drug program
-
Beckett's Kicks Off Multi-Channel Dry January Campaign Across Retail, Subscription Services, and Influencer Partnerships
-
Anavex Life Sciences Receives FDA Feedback on Alzheimer’s Disease Program
-
Zai Lab Announces National Medical Products Administration (NMPA) Approval of AUGTYRO™ (repotrectinib) for Patients with NTRK-Positive Solid Tumors
-
Arrowhead Pharmaceuticals Announces Interim Clinical Data on RNAi-based Obesity Candidates Showing Weight Loss in Obese Patients with Diabetes and Improved Measures of Body Composition
-
Biocon Biologics to Expand Biosimilar Oncology Portfolio, Outline Strategic Vision at the 2026 J.P. Morgan Healthcare Conference
-
Ionis to present at 44th Annual J.P. Morgan Healthcare Conference
-
Cartesian Therapeutics Announces New Employment Inducement Grants
-
Variant Bio Launches Inference, the World's First Agentic AI Genomic Drug Discovery Platform
-
Genprex reports preclinical data for diabetes gene therapy GPX-002
-
Genprex Announces Positive Preliminary Preclinical Data from Study of GPX-002 in Type 2 Diabetic Animal Studies
-
BitMart Officially Launches Prediction Market, Supporting Crypto and Popular Event Forecast Trading
-
Oversight Earns 2026 Great Place To Work Certification™ for Fifth Consecutive Year
-
West Point Gold Delivers Multiple High-Grade Intercepts at Northeast Tyro, Including 27.4m of 9.56 g/t Au from 71.6m
-
New Jersey Resources Schedules Fiscal 2026 First Quarter Earnings Call
-
Variant Bio Announces Strategic Target Discovery Collaboration with Boehringer Ingelheim for Kidney Disease
-
PureTech to Present at 44th Annual J.P. Morgan Healthcare Conference
-
Fortrea to Present at Upcoming J.P. Morgan Healthcare Conference
-
BitMEX Launches Equity Perps for 24/7 Stock Trading
-
Aclaris reports positive phase 1a results for ATI-052 bispecific antibody
-
Aclaris Therapeutics Announces Positive Interim Results of Phase 1a Trial of Anti-TSLP/IL-4Rα Bispecific Antibody ATI-052 Supporting Expedited Clinical Development
-
Phase 6 Goes Live: Blazpay AI Crypto Presale Opens at $0.0155 With $2.23M Raised
-
22nd Century files FDA renewal for VLN reduced nicotine cigarettes
-
22nd Century Files VLN® MRTP Renewal – Only Combustible Tobacco Product Authorized by the FDA Specifically to Help Smokers Smoke Less
-
Himax and Vuzix unveil AR glasses reference design for CES 2026
-
Himax and Vuzix to Introduce a Lightweight Prescription-Ready Optical Reference Design for AR Glasses at CES 2026
-
Hummingbird Bioscience Announces First Patient Dosed in Phase I Clinical Trial of HMBD-501 in Advanced HER3-Expressing Solid Malignancies
-
PRWireNOW Announces an Update on Colombian Press Release Package with New PR Pricing
-
TOKYO SKYTREE and "PUELLA MAGI MADOKA MAGICA" Holding 1st Collaborative Event from January 8 to April 6, 2026
-
DMG Blockchain Solutions Announces December Preliminary Operational Results
-
URBANICA Debuts Easy Install Monitor Arm and Laptop Stands for Compact Workspaces
-
HII Hosts Secretary of War Pete Hegseth at Newport News Shipbuilding
-
ASUS Republic of Gamers Presents Next-Gen Gaming Innovations, Commemorates 20 Years of Gaming Excellence at CES 2026
-
Purepoint Uranium Announces Grant of Options and Restricted Share Units
-
U.S. Postal Service Is Strengthening Requirements For Contracted Trucking Providers
-
Cyclerion partners with Medsteer for depression treatment development
-
Cyclerion Therapeutics Announces Strategic Agreement with Medsteer and Progress Toward Initiating Phase 2 Proof-of-Concept Study for CYC-126 in Treatment-Resistant Depression
-
Canadian Securities Exchange Welcomes Listing of Upside Gold Corp
-
NxGen Brands, Inc. (OTC: NXGB) Announces Launch of Candy Crew Community and CAND Token to Power Its Blockchain-Enabled Affiliate Rewards Program
-
Digitalage Activates Live News Feeds With Creator Economics That Redefine Media Distribution
-
XGIMI Goes Beyond the Screen at CES 2026 with MEMOMIND, Its First Pair of AI Glasses

